Combined metabolomic and network pharmacology approach analysis found that chelerythrine and sanguinarine in Corydalis saxicola Bunting are potentially active compounds in the treatment of liver fibrosis by modulating ALT activity [51]. The gene discussed is GPT; the disease is Hepatic fibrosis.